Skip to menu Skip to content Skip to footer

2015

Journal Article

Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2015). Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients. Peritoneal Dialysis International, 35 (1), 35-42. doi: 10.3747/pdi.2013.00272

Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients

2015

Conference Publication

Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cells

Ellis, R. J., Small, D. M., Ng, K. L., Vesey, D. A., Vitetta, L., Francis, R., Morais, C. and Gobe, G. C. (2015). Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cells. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543

Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cells

2015

Conference Publication

Small intestinal permeability is elevated in chronic viral hepatitis prior to the development of cirrhosis, and is associated with the degree of fibrosis

Raj, A. S., Holtmann, G., Fletcher, L., Bhat, P., Tran, C., Black, M., Nath, K., Jao, W., Vesey, D. and Macdonald, G. A. (2015). Small intestinal permeability is elevated in chronic viral hepatitis prior to the development of cirrhosis, and is associated with the degree of fibrosis. 50th International Liver Congress of the European Association for the Study of the Liver, Vienna, Austria, 22-26 April, 2015. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S0168-8278(15)30748-0

Small intestinal permeability is elevated in chronic viral hepatitis prior to the development of cirrhosis, and is associated with the degree of fibrosis

2014

Journal Article

Pathway-selective antagonism of proteinase activated receptor 2

Suen, J. Y., Cotterell, A., Lohman, R. J., Lim, J., Han, A., Yau, M. K., Liu, L., Cooper, M. A., Vesey, D. A. and Fairlie, D. P. (2014). Pathway-selective antagonism of proteinase activated receptor 2. British Journal of Pharmacology, 171 (17), 4112-4124. doi: 10.1111/bph.12757

Pathway-selective antagonism of proteinase activated receptor 2

2014

Journal Article

Thimerosal induces apoptotic and fibrotic changes to kidney epithelial cells in vitro

Hornos Carneiro, Maria Fernanda, Morais, Christudas, Small, David M., Vesey, David A., Barbosa Jr, Fernando and Gobe, Glenda C. (2014). Thimerosal induces apoptotic and fibrotic changes to kidney epithelial cells in vitro. Environmental Toxicology, 30 (12), 1423-1433. doi: 10.1002/tox.22012

Thimerosal induces apoptotic and fibrotic changes to kidney epithelial cells in vitro

2014

Journal Article

Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury

Gobe, Glenda C., Bennett, Nigel C., West, Malcolm, Colditz, Paul, Brown, Lindsay, Vesey, David A. and Johnson, David W. (2014). Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury. American Journal of Physiology-Renal Physiology, 306 (6), F681-F692. doi: 10.1152/ajprenal.00241.2013

Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury

2014

Journal Article

Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy

Morais, Christudas, Small, David M., Vesey, David A., Martin, Jennifer, Johnson, David W. and Gobe, Glenda C. (2014). Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochemical and Biophysical Research Communications, In Press, Corrected Proof (3), 1-6. doi: 10.1016/j.bbrc.2014.01.047

Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy

2014

Journal Article

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

2014

Conference Publication

Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunction

Ward, M. S., Flemming, N. B., Gallo, L. A., Fotheringham, A., Gobe, G., Vesey, D. and Forbes, J. M. (2014). Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunction. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne Australia, 25–27 August 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunction

2014

Conference Publication

Decreasing apoptosis repressor with caspase recruitment domain (ARC) is associated with disease progression and drug resistance of renal cell carcinoma

Ng, K. L., Wood, S. T., Ding, J. C., Jayasuriya, T. S., Vesey, D. A., Gobe, G. C. and Morais, C. (2014). Decreasing apoptosis repressor with caspase recruitment domain (ARC) is associated with disease progression and drug resistance of renal cell carcinoma. 67th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane, Australia, Mar 16-19, 2014. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.12618

Decreasing apoptosis repressor with caspase recruitment domain (ARC) is associated with disease progression and drug resistance of renal cell carcinoma

2014

Conference Publication

Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques

Raj, Ashok, Holtmann, Gerald, Bhat, Purnima, Fletcher, Linda, Tran, Cuong, Vesey, David and Macdonald, Graeme (2014). Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques. Asian Pacific Digestive Week, Bali, Indonesia, 22‐25, 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia . doi: 10.1111/jgh.12766_2

Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques

2013

Journal Article

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

Rossi, M., Campbell, K.L., Johnson, D.W., Stanton, T., Vesey, D.A., Coombes, J.S., Weston, K.S., Hawley, C.M., McWhinney, B.C., Ungerer, J.P.J. and Isbel, N. (2013). Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease. Archives of Medical Research, 45 (4), 309-317. doi: 10.1016/j.arcmed.2014.04.002

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

2013

Journal Article

Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney

Gobe, Glenda C., Morais, Christudas, Vesey, David A. and Johnson, David W. (2013). Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney. Journal of Nephropathology, 2 (3), 154-165. doi: 10.12860/JNP.2013.27

Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney

2013

Journal Article

PAR2-induced inflammatory responses in human kidney tubular epithelial cells

Vesey, David A., Suen, Jacky Y., Seow, Vernon, Lohman, Rink-Jan, Liu, Ligong, Gobe, Glenda C., Johnson, David W. and Fairlie, David P. (2013). PAR2-induced inflammatory responses in human kidney tubular epithelial cells. American Journal of Physiology - Renal Physiology, 304 (6), F737-F750. doi: 10.1152/ajprenal.00540.2012

PAR2-induced inflammatory responses in human kidney tubular epithelial cells

2013

Conference Publication

Curcumin attenuates growth of established renal cell carcinoma through suppression of nuclear factor-kappa B

Morais, C., Vesey, D., Johnson, D., Wood, S. and Gobe, G. (2013). Curcumin attenuates growth of established renal cell carcinoma through suppression of nuclear factor-kappa B. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12121

Curcumin attenuates growth of established renal cell carcinoma through suppression of nuclear factor-kappa B

2013

Conference Publication

Erythropoietin Delivered for Protection From Acute Kidney Injury May Have Secondary Benefits in Protecting Heart

Morais, Christudas, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2013). Erythropoietin Delivered for Protection From Acute Kidney Injury May Have Secondary Benefits in Protecting Heart. 50th European Renal Association European Dialysis and Transplant Association Congress, Istanbul Turkey, 18-21 May 2013. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gft107

Erythropoietin Delivered for Protection From Acute Kidney Injury May Have Secondary Benefits in Protecting Heart

2013

Journal Article

Functional significance of erythropoietin in renal cell carcinoma

Morais, Christudas, Johnson, David W., Vesey, David A. and Gobe, Glenda C. (2013). Functional significance of erythropoietin in renal cell carcinoma. BMC Cancer, 13 (1) 14, 14.1-14.7. doi: 10.1186/1471-2407-13-14

Functional significance of erythropoietin in renal cell carcinoma

2012

Journal Article

Evidence for steroidogenic potential in human prostate cell lines and tissues

Bennett, Nigel C., Hooper, John D., Lambie, Duncan, Lee, Cheok S., Yang, Tao, Vesey, David A., Samaratunga, Hemamali, Johnson, David W. and Gobe, Glenda C. (2012). Evidence for steroidogenic potential in human prostate cell lines and tissues. American Journal of Pathology, 181 (3), 1078-1087. doi: 10.1016/j.ajpath.2012.06.009

Evidence for steroidogenic potential in human prostate cell lines and tissues

2012

Journal Article

Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: Potential for targeted therapy

Rajandram, Retnagowri, Bennett, Nigel C., Wang, Zhiqiang, Perry-Keene, Joanna, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2012). Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: Potential for targeted therapy. Pathology, 44 (5), 453-459. doi: 10.1097/PAT.0b013e3283557748

Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: Potential for targeted therapy

2012

Journal Article

An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats

Lohman, Rink-Jan, Cotterell, Adam J., Barry, Grant D., Liu, Ligong, Suen, Jacky Y., Vesey, David A. and Fairlie, David P. (2012). An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats. The FASEB Journal, 26 (7), 2877-2887. doi: 10.1096/fj.11-201004

An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats